Brief Description
The purpose of this study is to gather long-term observational data in order to help understand the biology behind nephrotic syndrome.
Estimated Enrollment
1200
Trial is for people with
Primary focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN), or minimal change disease (MCD)
Study Goal
NEPTUNE seeks to increase the understanding and improve treatment of rare forms of Nephrotic Syndrome.
What is involved for the patient?
Patients will be asked to allow researchers to access medical history. The study team may also collect biosamples (blood, urine, ...
Find other locations for this trial:
Winston-Salem, NC